HOLUBIAK MYRON Z has filed 20 insider transactions across 2 companies since April 2024.
Most recent transaction: a grant/award of 850000 shares of CITIUS ONCOLOGY, INC. ($CTOR) on September 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 850000 | $0.00 | 850,000.0000 | 71,552,402 | 9999.99% | 1.19% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 850000 | $0.00 | 850,000.0000 | 71,552,402 | 9999.99% | 1.19% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 100000 | $0.00 | 950,000.0000 | 71,552,402 | 11.76% | 0.14% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 850000 | $0.00 | 950,000.0000 | 71,552,402 | 850.00% | 1.19% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 31373 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 0.29% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 31373 | $0.00 | 31,373.0000 | 11,006,896 | 9999.99% | 0.29% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 22344 | $0.00 | 0.0000 | 11,006,896 | 100.00% | 0.20% |
| Aug. 8, 2025 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 22344 | $0.00 | 22,344.0000 | 11,006,896 | 9999.99% | 0.20% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Secretary | A | Stock Option (Right to Buy) | 300000 | $0.00 | 1,850,000.0000 | 68,053,607 | 19.35% | 0.44% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Secretary | A | Stock Option (Right to Buy) | 50000 | $0.00 | 1,850,000.0000 | 68,053,607 | 2.78% | 0.07% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Stock Option (Right to Purchase Common Stock) | 350000 | $0.00 | 2,716,667.0000 | 6,726,999 | 14.79% | 5.20% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 6,726,999 | 9999.99% | 1.11% |
| Sept. 25, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 558597 | $0.00 | 129,450.0000 | 6,954,278 | 81.19% | 8.03% |
| Sept. 25, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 558597 | $0.00 | 688,047.0000 | 6,954,278 | 431.52% | 8.03% |
| Aug. 14, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 784314 | $0.00 | 913,764.0000 | 6,954,278 | 605.88% | 11.28% |
| Aug. 14, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 784314 | $0.00 | 129,450.0000 | 6,954,278 | 85.83% | 11.28% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Director | A | Stock Option (Right to Buy) | 1500000 | $0.00 | 1,500,000.0000 | 67,500,000 | 9999.99% | 2.22% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | HOLUBIAK MYRON Z | Director | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 67,500,000 | 9999.99% | 0.74% |
| April 3, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | D | Warrant to Purchase Common Stock | 129450 | $0.00 | 1,342,911.0000 | 6,362,890 | 8.79% | 2.03% |
| April 3, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | HOLUBIAK MYRON Z | Vice Chairman | A | Warrant to Purchase Common Stock | 129450 | $0.00 | 1,472,361.0000 | 6,362,890 | 9.64% | 2.03% |